IXEMPRA Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

IXEMPRA General Information

Description

An anti-cancer chemotherapy drug. The drug is classified as an antimicrotubule agent and is used in the treatment of advanced breast cancer.

Contact Information

Website
www.ixempra.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Acquirer
Primary Office
  • 345 Park Avenue
  • New York, NY 10154
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IXEMPRA Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IXEMPRA‘s full profile, request access.

Request a free trial

IXEMPRA Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IXEMPRA‘s full profile, request access.

Request a free trial